Role of nitric oxide in angiogenesis and microcirculation in tumors
暂无分享,去创建一个
[1] T. Sugimura,et al. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. , 1997, Cancer research.
[2] I. Fidler,et al. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. , 1997, Journal of the National Cancer Institute.
[3] G. Tozer,et al. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. , 1997, Cancer research.
[4] R. Jain,et al. Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production, and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] R. Jain,et al. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. , 1997, The American journal of pathology.
[6] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[7] G. Rosner,et al. Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure. , 1997, Radiation research.
[8] W. Zapol,et al. Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. , 1996, The American journal of physiology.
[9] M. Stratford,et al. Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification. , 1996, British Journal of Cancer.
[10] H. Granger,et al. VEGF induces NO-dependent hyperpermeability in coronary venules. , 1996, The American journal of physiology.
[11] R. Hobson,et al. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury. , 1996, Microvascular research.
[12] K. Black,et al. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. , 1996, Cancer research.
[13] R K Jain,et al. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. , 1996, The American journal of pathology.
[14] H. Saito,et al. Role in nitric oxide in Kupffer cell–mediated hepatoma cell cytotoxicity in vitro and ex vivo , 1996, Hepatology.
[15] R. Jain,et al. Leukocyte-endothelial adhesion and angiogenesis in tumors , 1996, Cancer and Metastasis Reviews.
[16] H. Maeda,et al. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth , 1996, Cancer.
[17] P. K. Lala,et al. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. , 1996, British Journal of Cancer.
[18] R. Jain,et al. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. , 1995, Cancer research.
[19] M. Moskowitz,et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.
[20] P. Kubes. Nitric Oxide Affects Microvascular Permeability in the Intact and Inflamed Vasculature , 1995, Microcirculation.
[21] W. Durán,et al. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. , 1995, Microvascular research.
[22] G. Karakiulakis,et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO‐releasing vasodilators, isosorbide mononitrate and dinitrate , 1995, British journal of pharmacology.
[23] P. Libby,et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.
[24] Richard Graham Knowles,et al. Nitric oxide synthase activity in human breast cancer. , 1995, British Journal of Cancer.
[25] M. Dewhirst,et al. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. , 1995, British Journal of Cancer.
[26] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[27] P Rhodes,et al. Roles of nitric oxide in tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[28] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[29] P. Barnes. Cyclic nucleotides and phosphodiesterases and airway function. , 1995, The European respiratory journal.
[30] K. Aldape,et al. Expression of nitric oxide synthase in human central nervous system tumors. , 1995, Cancer research.
[31] C. Thiemermann,et al. Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine. , 1994, Cancer research.
[32] S Amerini,et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.
[33] L. Ellis,et al. The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.
[34] Y. Uchida,et al. Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.
[35] A. M. Lefer,et al. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. , 1994, Gastroenterology.
[36] U. Walter,et al. NO at work , 1994, Cell.
[37] Carl Nathan,et al. Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.
[38] R K Jain,et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.
[39] A. Koch,et al. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] H. Maeda,et al. Enhanced Vascular Permeability in Solid Tumor Is Mediated by Nitric Oxide and Inhibited by Both New Nitric Oxide Scavenger and Nitric Oxide Synthase Inhibitor , 1994, Japanese journal of cancer research : Gann.
[41] P. Peristeris,et al. Evidence that nitric oxide is an endogenous antiangiogenic mediator , 1994, British journal of pharmacology.
[42] Richard Graham Knowles,et al. Nitric oxide synthase activity in human gynecological cancer. , 1994, Cancer research.
[43] S. Snyder,et al. Targeted disruption of the neuronal nitric oxide synthase gene , 1993, Cell.
[44] Xin-Yun Huang,et al. Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor , 1993, Cell.
[45] L. Buttery,et al. Induction of nitric oxide synthase in the neo‐vasculature of experimental tumours in mice , 1993, The Journal of pathology.
[46] J. Filep,et al. Modulation by nitric oxide of platelet‐activating factor‐induced albumin extravasation in the conscious rat , 1993, British journal of pharmacology.
[47] S. Moncada,et al. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat , 1993, British journal of pharmacology.
[48] H. Granger,et al. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. , 1993, Biochemical and biophysical research communications.
[49] R. Jain,et al. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.
[50] H. Granger,et al. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. , 1993, The American journal of physiology.
[51] M. Maragoudakis,et al. Nitric oxide is involved in the regulation of angiogenesis , 1993, British Journal of Pharmacology.
[52] I. Hart,et al. Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature , 1992, British journal of pharmacology.
[53] S. Moncada. The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. , 1992, Acta physiologica Scandinavica.
[54] P. Kubes,et al. Nitric oxide modulates microvascular permeability. , 1992, The American journal of physiology.
[55] P. Kubes,et al. Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[56] L. Ignarro. Endothelium‐derived nitric oxide: actions and properties , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] Tetsurou Yamamoto,et al. Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue , 1988, Japanese journal of cancer research : Gann.
[58] R K Jain,et al. Determinants of tumor blood flow: a review. , 1988, Cancer research.
[59] R. Puri,et al. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. , 1988, Journal of the National Cancer Institute.
[60] R. Weinberg,et al. A molecular basis of cancer. , 1983, Scientific American.
[61] A. Gozhenko,et al. [Role of nitric oxide in tumor growth]. , 2004, Uspekhi fiziologicheskikh nauk.
[62] Seaver,et al. Nitric oxide as a secretory product of mammalian cells , 2004 .
[63] Rakesh K. Jain,et al. Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.
[64] R. Jain,et al. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. , 1996, Nature medicine.
[65] H. Granger,et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.
[66] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[67] G. Tozer,et al. The influence of nitric oxide on tumour vascular tone. , 1995, Acta oncologica.
[68] P. López-Jaramillo,et al. The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.